Uveitis Clinical Trial
Official title:
The Impact of Uveitis on Health-related Quality of Life in Adolescents
Verified date | December 2011 |
Source | Hospital Hietzing |
Contact | n/a |
Is FDA regulated | No |
Health authority | Austria: Ethikkommission |
Study type | Observational |
Data about psychodynamics in uveitis patients are scare. A negative impact of disease is
described not only in adult patients with active, but also with quiescent disease. During
adolescence even less is known about psychodynamics although this is an especially sensible
and challenging stage of life. Given the assumption that juvenile patients with quiescent
disease still could suffer from emotional distress, this would require special attention.
In this study the investigators evaluate the impact of juvenile uveitis on HRQoL and
attempted to identify clinical and demographic factors contributing to an impaired health
status. The investigators limit the study to patients with quiescent uveitis and good visual
function in at least one eye to exclude additional negative stressors. As there are no
validated uveitis-specific psychometric questionnaires evaluating QoL available yet, the
investigators use age-appropriate generic instruments. This should allow obtaining an
overview about the adolescents' general Health-related Quality of Life (HRQoL) and whether
psychological interventions should be offered to this sensitive patient group.
Status | Completed |
Enrollment | 37 |
Est. completion date | July 2009 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 11 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Patients with uveitis - aged 11-18 years - willing to participate - parent or legal guardian agrees with participation of adolescent Exclusion Criteria: - not willing to participate - parent or legal guardian does not agree with participation of adolescent |
Observational Model: Cohort
Country | Name | City | State |
---|---|---|---|
Austria | Medical University of Vienna | Vienna |
Lead Sponsor | Collaborator |
---|---|
Hospital Hietzing | Medical University of Vienna |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quality of life as assessed with the "Inventory for Assessing the Quality of Life in Children and Adolescents" | psychometric inventory | One day | No |
Secondary | Quality of life as assessed with the "Children Quality of Life Questionnaire" | psychometric inventory | One day | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101604 -
Biomarkers of Common Eye Diseases
|
||
Active, not recruiting |
NCT04704609 -
Imaging Quantification of Inflammation (IQI)
|
||
Completed |
NCT03173144 -
Chronic Inflammatory Disease, Lifestyle and Treatment Response
|
||
Withdrawn |
NCT01280669 -
Intravitreal Sirolimus as Therapeutic Approach to Uveitis
|
Phase 2 | |
Terminated |
NCT02907814 -
Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
|
N/A | |
Active, not recruiting |
NCT02252328 -
Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients
|
Phase 2/Phase 3 | |
Completed |
NCT04183387 -
Simvastatin in Uveitis
|
Phase 2 | |
Completed |
NCT01983488 -
Clinical Outcome in Uveitis
|
||
Withdrawn |
NCT00499551 -
A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
|
Phase 1/Phase 2 | |
Terminated |
NCT00114062 -
Study to Treat Uveitis Associated Macular Edema
|
Phase 2 | |
Completed |
NCT00132691 -
Multicenter Uveitis Steroid Treatment (MUST) Trial
|
Phase 4 | |
Completed |
NCT00476593 -
Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications
|
N/A | |
Completed |
NCT00001867 -
Effect of Pregnancy on Uveitis
|
N/A | |
Completed |
NCT00379275 -
Eye and Immunogenetic Features of Sarcoidosis
|
N/A | |
Active, not recruiting |
NCT03828019 -
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
|
Phase 3 | |
Terminated |
NCT01939691 -
Macular Edema Nepafenac vs. Difluprednate Uveitis Trial
|
Phase 4 | |
Active, not recruiting |
NCT03889860 -
Objective Choroidal Thickness Measurements in Uveitis
|
||
Completed |
NCT00070759 -
Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
|
Phase 2 | |
Recruiting |
NCT05486468 -
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
|
Phase 3 | |
Active, not recruiting |
NCT05385757 -
UNICORNS: Uveitis in Childhood Prospective National Cohort Study
|